Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery
Clinical trial NCT02034019 · COMPLETED
Trial details
- NCT number
- NCT02034019
- Sponsor
- Ocular Therapeutix, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-12-01
- Enrollment
- 247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.